John F Paolini Selected Research

Interferons

1/2022

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John F Paolini Research Topics

Disease

11	Flushing 08/2012 - 07/2007
10	Pericarditis 03/2024 - 10/2020
8	Inflammation (Inflammations) 01/2022 - 01/2014
7	Atrial Fibrillation 07/2014 - 09/2011
7	Stroke (Strokes) 07/2014 - 09/2011
7	Dyslipidemias (Dyslipidemia) 03/2010 - 09/2004
6	Embolism (Embolus) 07/2014 - 09/2011
5	Hemorrhage 07/2014 - 09/2011
4	Pain (Aches) 10/2022 - 10/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 01/2009
3	Pruritus (Itching) 03/2023 - 07/2007
3	Atherosclerosis 06/2017 - 01/2014
3	Atherosclerotic Plaque (Atheroma) 06/2017 - 12/2014
2	Prurigo 03/2023 - 01/2021
2	Heart Failure 01/2023 - 05/2014
2	Giant Cell Arteritis (Horton Disease) 01/2022 - 01/2022
2	Vascular System Injuries 01/2022 - 01/2003
2	COVID-19 06/2021 - 08/2020
2	Pneumonia (Pneumonitis) 06/2021 - 08/2020
2	Acute Coronary Syndrome 06/2017 - 12/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2017 - 12/2014
2	Rare Diseases (Rare Disease) 05/2015 - 03/2015
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2014 - 09/2011
2	Transient Ischemic Attack 05/2014 - 03/2014
2	Hypercholesterolemia 05/2009 - 01/2009
1	Diastolic Heart Failure 01/2023
1	Thrombotic Microangiopathies 01/2023
1	Necrosis 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 06/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Injection Site Reaction 01/2021
1	Cardiac Tamponade 12/2020
1	Constrictive Pericarditis 12/2020
1	Fever (Fevers) 08/2020
1	Homozygous Familial Hypercholesterolemia 05/2015
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 03/2015

Drug/Important Bio-Agent (IBA)

12	Niacin (Nicotinic Acid)FDA LinkGeneric 08/2012 - 07/2007
9	MK-0524IBA 11/2010 - 03/2008
8	rilonacept FDA Link 03/2024 - 10/2020
8	LipidsIBA 01/2014 - 10/2008
7	RivaroxabanIBA 07/2014 - 09/2011
6	CytokinesIBA 03/2024 - 01/2021
6	CER-001IBA 06/2017 - 01/2014
6	Warfarin (Coumadin)FDA LinkGeneric 07/2014 - 09/2011
5	C-Reactive ProteinIBA 06/2021 - 10/2020
5	ProstaglandinsIBA 08/2012 - 03/2008
4	mavrilimumabIBA 01/2022 - 08/2020
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 08/2020
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2014 - 11/2007
3	Interleukin-1alpha (Interleukin 1 alpha)IBA 03/2024 - 10/2022
3	Monoclonal AntibodiesIBA 03/2023 - 08/2020
3	HDL LipoproteinsIBA 06/2017 - 12/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2015 - 01/2009
3	CholesterolIBA 03/2015 - 01/2014
3	Vitamin K FDA Link 07/2014 - 03/2014
3	Factor Xa (Coagulation Factor Xa)IBA 07/2014 - 03/2014
3	TabletsIBA 05/2009 - 11/2008
2	Oncostatin MIBA 03/2023 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 01/2023 - 01/2021
2	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022 - 06/2021
2	Colchicine FDA LinkGeneric 02/2021 - 10/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 10/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2015 - 01/2015
2	LDL CholesterolIBA 05/2015 - 10/2008
2	Lipoproteins (Lipoprotein)IBA 03/2015 - 07/2009
2	Factor Xa InhibitorsIBA 07/2014 - 10/2011
2	CreatinineIBA 07/2014 - 03/2014
2	prostaglandin D2 receptorIBA 04/2009 - 11/2008
2	Prostaglandin D2IBA 04/2009 - 11/2008
1	SuspensionsIBA 03/2024
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 03/2023
1	Immunoglobulin A (IgA)IBA 03/2023
1	InterleukinsIBA 03/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	InterferonsIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	InflammasomesIBA 02/2021
1	ZymosanIBA 02/2021
1	Oncostatin M Receptor beta SubunitIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2015
1	oxidized low density lipoproteinIBA 05/2015
1	SterolsIBA 03/2015
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	Apolipoproteins E (ApoE)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	ATP Binding Cassette Transporter 1IBA 01/2015

Therapy/Procedure

10	Therapeutics 03/2024 - 11/2007
1	Duration of Therapy 03/2024
1	Heterologous Transplantation (Xenotransplantation) 01/2023
1	Polypharmacy 01/2023
1	Extracorporeal Membrane Oxygenation 01/2023
1	Episode of Care 10/2021
1	Immunomodulation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 08/2020